Imipramine Hydrochloride

Product NDC
70518-2047
11-digit product format
705182047
Labeler code
70518
Product ID
70518-2047_c5d69a59-3818-b2df-e053-2995a90a8e85
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Imipramine Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA088276
Marketing category
ANDA
Marketing start
2019-04-29
Marketing end
0000-00-00
Substance
IMIPRAMINE HYDROCHLORIDE
Active strength
50 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2047-02023-03-09C16284748780-1f386c649-c335-0266-e053-dadaa90a7c1a997d4bb3-a4e2-4fac-a408-2b2d626b7fad
70518-2047-02023-01-30C16284748780-1f386c649-c335-0266-e053-dadaa90a7c1a997d4bb3-a4e2-4fac-a408-2b2d626b7fad

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2047-07051820470030 TABLET in 1 BLISTER PACK (70518-2047-0) 30 tablet2019-04-290000-00-00NoNoCurrent